*This content was translated by AI.
KGC Ginseng Corporation and Pulmuone Healthcare have formed an alliance.
Through this business agreement, KGC Ginseng Corporation plans to develop new programs based on the professional capabilities of both companies in the health food development field and expand and lead the continuously growing blood sugar care and senior health food market by utilizing both companies' platforms.
KGC Ginseng Corporation plans to jointly develop and sell subscription programs using its blood sugar management brand "GLPro" through both companies' specialized platforms in March. "GELPRO" is a brand specializing in blood sugar care launched by KGC Ginseng Corporation in 2024 after being officially recognized by the Ministry of Food and Drug Safety for its blood sugar control function, and is expected to expand the blood sugar care market by further expanding consumer contact points through this collaboration.
It will also join forces to explore the rapidly growing senior health food market. Currently, the size of the domestic senior food market has grown from about 4.4 trillion won in 2020 to about 5.6 trillion won in 2025, according to an announcement by the Korea Health Industry Development Institute.
Along with Pulmuone Healthcare, KGC Ginseng Corporation plans to develop a senior-target premium health diet using red ginseng ingredients from the standardized premium red ginseng ingredient brand "G1899" and pioneer and lead the senior health food market through analysis of the senior market based on data from both companies.
"By combining KGC's excellent product competitiveness with Pulmuone Healthcare's differentiated platform and know-how, it is of great significance to create synergy between the two companies to expand the premium health food market and continue to grow blood sugar care," said an official from KGC Ginseng Corporation who spoke to this newspaper by phone.
<© STARNEWS. All rights reserved. No reproduction or redistribution allowed.>
*This content was translated by AI.
